Update on Glaucoma: Pathogenesis and Treatment

Dear Colleagues,

For over 100 years, the only therapy used for glaucoma has only been hypertensive. At present, we are trying to understand if there are other therapeutic possibilities beyond these. In fact, glaucoma is a multifactorial disease where proapoptotic signals develop towards retinal ganglion cells. In light of the new pathogenetic acquisitions, it is possible to hypothesize the use of new therapeutic approaches to combat this complex disease. The purpose of this Special Issue is to illustrate the new developments that are taking place in the study of glaucoma from pathogenesis to its therapy.

Prof. Dr. Sergio Claudio Saccà
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.